Comparative PK [Study Per­for­mance]

posted by PVRC – India, 2021-05-10 18:12 (139 d 12:22 ago) – Posting: # 22338
Views: 877

Hi all,

For one of the product, the agency recommend to demonstrate comparative PK in the absence of bioequivalence. The question is that whether all bioequivalence criteria (like 80-125%, group effect etc.,) are still applicable to demonstrate comparative PK.

Thanks in advance....

Complete thread:

 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Monday 06:35 CEST (Europe/Vienna)

In the beginner’s mind there are many possibilities.
In the expert’s mind there are few.    Shunryu Suzuki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz